Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Dressel

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Atherosclerosis|August 17, 2021
Cutaneous manifestations in familial hypercholesterolaemiaJulius L Katzmann, Maximilian Lehmann, Adrienn Tünnemann-Tarr, et al.
Journal of Neurology|January 13, 2005
Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1bAndreas Bitsch, Alexander Dressel, Kathrin Meier, et al.
The EPMA Journal|September 4, 2018
A new non-invasive diagnostic tool in coronary artery disease: artificial intelligence as an essential element of predictive, preventive, and personalized medicineMichael J Zellweger, Andrew Tsirkin, Vasily Vasilchenko, et al.
BMC Neuroscience|April 10, 2010
Cerebrospinal fluid promotes survival and astroglial differentiation of adult human neural progenitor cells but inhibits proliferation and neuronal differentiationJudith Buddensiek, Alexander Dressel, Michael Kowalski, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 12, 2008
Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluidAnastassia Gontsarova, Eckhard Kaufmann, Hayrettin Tumani, et al.
Vascular Pharmacology|June 18, 2019
Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohortAlexander Dressel, Burkhard Schmidt, Nina Schmidt, et al.
Frontiers in Neurology|December 17, 2020
Stroke-Induced Modulation of Myeloid-Derived Suppressor Cells (MDSCs) and IL-10-Producing Regulatory MonocytesLennart Achmus, Johanna Ruhnau, Sascha Grothe, et al.
Diagnostic Microbiology and Infectious Disease|November 26, 2021
Evaluation of five widely used serologic assays for antibodies to SARS-CoV-2Christopher Stocking, Laura de Miguel, Gabriela Suteu, et al.
Journal of Neuroinflammation|July 23, 2017
Ischaemic stroke and the recanalization drug tissue plasminogen activator interfere with antibacterial phagocyte functionAntje Vogelgesang, Claudia Lange, Lara Blümke, et al.
Frontiers in Neurology|October 12, 2020
Corrigendum: Clinical Improvement Following Stroke Promptly Reverses Post-stroke Cellular Immune AlterationsAntje Vogelgesang, Carl Witt, Christin Heuer, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Atherosclerosis|August 17, 2021
Cutaneous manifestations in familial hypercholesterolaemiaJulius L Katzmann, Maximilian Lehmann, Adrienn Tünnemann-Tarr, et al.
Journal of Neurology|January 13, 2005
Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1bAndreas Bitsch, Alexander Dressel, Kathrin Meier, et al.
The EPMA Journal|September 4, 2018
A new non-invasive diagnostic tool in coronary artery disease: artificial intelligence as an essential element of predictive, preventive, and personalized medicineMichael J Zellweger, Andrew Tsirkin, Vasily Vasilchenko, et al.
BMC Neuroscience|April 10, 2010
Cerebrospinal fluid promotes survival and astroglial differentiation of adult human neural progenitor cells but inhibits proliferation and neuronal differentiationJudith Buddensiek, Alexander Dressel, Michael Kowalski, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 12, 2008
Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluidAnastassia Gontsarova, Eckhard Kaufmann, Hayrettin Tumani, et al.
Vascular Pharmacology|June 18, 2019
Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohortAlexander Dressel, Burkhard Schmidt, Nina Schmidt, et al.
Frontiers in Neurology|December 17, 2020
Stroke-Induced Modulation of Myeloid-Derived Suppressor Cells (MDSCs) and IL-10-Producing Regulatory MonocytesLennart Achmus, Johanna Ruhnau, Sascha Grothe, et al.
Diagnostic Microbiology and Infectious Disease|November 26, 2021
Evaluation of five widely used serologic assays for antibodies to SARS-CoV-2Christopher Stocking, Laura de Miguel, Gabriela Suteu, et al.
Journal of Neuroinflammation|July 23, 2017
Ischaemic stroke and the recanalization drug tissue plasminogen activator interfere with antibacterial phagocyte functionAntje Vogelgesang, Claudia Lange, Lara Blümke, et al.
Frontiers in Neurology|October 12, 2020
Corrigendum: Clinical Improvement Following Stroke Promptly Reverses Post-stroke Cellular Immune AlterationsAntje Vogelgesang, Carl Witt, Christin Heuer, et al.
Pageof 8